Abstract.
Objective: To establish a drug screening system based on transcriptional regulation of microsomal PGE2 synthase 1 (mPGES-1), cyclooxygenase 1 (COX-1) and 2 (COX-2) for discovering selective down-regulators of mPGES-1.
Methods: The upstream regulatory sequences of mPGES-1, COX-1, COX-2 were respectively cloned into pGL3B-neo vector containing luciferase gene and neomycin resistance gene (the pGL3B-neo vector had been previously constructed by cloning the neomycin resistance gene into the Sal I site of the pGL3-Basic vector). After that, the recombinant reporter gene vectors pGL3B-neo/mPGES-1, pGL3B-neo/COX-1, pGL3B-neo/COX-2 were respectively transfected into A549 cells and therefore stable cell lines, namely M 1, M 2 and M 3, were obtained. Samples were detected then by testing luciferase activity of M 1, M 2 and M 3 cells in microtiter wells to identify compounds that can selectively down-regulate mPGES-1 expression. Through luciferase activity testing, the compounds which had more than 40 % inhibition ratio on M 1 and less than 20 % inhibition ratio on M 2 and M 3 cells could be regarded as hits.
Results: Using the cell-based reporter gene assay, we screened compounds for selectively down-regulation of mPGES-1 expression and several compounds were discovered.
Conclusion: A cell-based drug screening system was established to screen selective down-regulators of mPGES-1 expression, and compound CM188 was identified, which might become a lead compound for novel anti-arthritic drugs.
Similar content being viewed by others
Abbreviations
- PG:
-
Prostaglandin
- AA:
-
arachidonic acid
- cPLA2:
-
cytosolic phospholipase A2
- COX:
-
cyclooxygenase
- PGES:
-
prostaglandin E synthase
- mPGES:
-
microsomal PGES
- RA:
-
rheumatoid arthritis
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 26 October 2005; returned for revision 19 November 2005; accepted by M. Katori 26 November 2005
Rights and permissions
About this article
Cite this article
Guo, L., Lian, J.H., Ji, W. et al. Establishment of a cell-based drug screening system for identifying selective down-regulators of mPGES-1. Inflamm. res. 55, 114–118 (2006). https://doi.org/10.1007/s00011-005-0061-x
Issue Date:
DOI: https://doi.org/10.1007/s00011-005-0061-x